Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117,273,296
-
Number of holders
-
227
-
Total 13F shares, excl. options
-
117,674,323
-
Shares change
-
+2,328,652
-
Total reported value, excl. options
-
$1,252,084,508
-
Value change
-
+$25,216,006
-
Put/Call ratio
-
84%
-
Number of buys
-
102
-
Number of sells
-
87
-
Price
-
$10.64
Institutional Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q4 2022
As of 31 Dec 2022 DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) had 264 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 117,674,323 shares of stock of the company.
Largest 10 holders included BlackRock Inc., FEDERATED HERMES, INC., STATE STREET CORP, VANGUARD GROUP INC, Chicago Capital, LLC, Fisher Asset Management, LLC, Bain Capital Life Sciences Investors, LLC, PFM Health Sciences, LP, BLAIR WILLIAM & CO/IL, and Deep Track Capital, LP.
This table shows 264 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.